1. Acknowledgement

   Acknowledgments 23 December 2012 Pages: 1097 - 1099

2. Continuous Time Simulation and Discretized Models for Cost-Effectiveness Analysis

   • Marta O. Soares
   • Luísa Canto e Castro

   Practical Application 23 December 2012 Pages: 1101 - 1117

   

3. Bevacizumab for Metastatic Colorectal Cancer

   • Sophie Whyte
   • Abdullah Pandor
   • Matt Stevenson

   Review Article 23 December 2012 Pages: 1119 - 1132

   

4. A Systematic Review and Critical Assessment of Health State Utilities

   • Scott Doyle
   • Andrew Lloyd
   • Alastair Gray

   Systematic Review 23 December 2012 Pages: 1133 - 1143

   

5. Cost Effectiveness of Therapeutic Interventions in Ankylosing Spondylitis

   • Cécile Gaujoux-Viala
   • Bruno Fautrel

   Systematic Review 23 December 2012 Pages: 1145 - 1156

   

6. Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis

   • Lanting Lu
   • Hilary Pearce
   • Ken Stein

   Original Research Article 23 December 2012 Pages: 1157 - 1171

   

7. Chemotherapy Administration

   • Philip Haywood
   • Johan de Raad
   • Robyn Ward

   Original Research Article 23 December 2012 Pages: 1173 - 1186

   

8. What’s Good and Bad About Contraceptive Products?

   • Stephanie A. Knox
   • Rosalie C. Viney
   • Deborah Bateson

   Original Research Article 23 December 2012 Pages: 1187 - 1202

   

9. Impact of Transformation of Negative Values and Regression Models on Differences Between the UK and US EQ-5D Time Trade-Off Value Sets

   • Liv Ariane Augestad
   • Kim Rand-Hendriksen
   • Knut Stavem

   Original Research Article 23 December 2012 Pages: 1203 - 1214